EquityZen Growth Technology Fund LLC - Series 1242
Raised
$158K
Investors
7
Min Invest
$10,001
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1242 is a Delaware-based pooled investment fund that raised $158K from 7 investors under Rule 506(b) and 3(c)(1) exemptions, with a $10K minimum investment. Filed March 2022 by EquityZen Advisors, this is one of approximately 1,889 related entities in the EquityZen platform focused on pre-IPO secondary transactions.
This pre-IPO fund vehicle uses the standard 506(b)/3(c)(1) exemption pairing typical of private secondary market platforms targeting accredited retail and HNW investors. The $10K minimum positions it at the lower accessibility tier relative to institutional pre-IPO vehicles, consistent with EquityZen's model of fractionalizing access to private company shares.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
